|
ACE1831 Clinical Trials
1 actively recruiting trial across 1 location
Orlando, Florida1 trial
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
AdventHealth Orlando
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.